SG Americas Securities
NAGE

SG Americas Securities’s Niagen Bioscience NAGE Stock Holding History

SG Americas Securities’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$77K Sell
17,424
-37,225
-68% -$201K ﹤0.01% 2981
2025
Q4 		$348K Buy
54,649
+2,950
+6% +$20.5K ﹤0.01% 2683
2025
Q3 		$482K Buy
+51,699
New +$522K ﹤0.01% 2149
2025
Q2 		– Sell
-17,261
Closed -$119K – 3726
2025
Q1 		$119K Sell
17,261
-6,596
-28% -$41.4K ﹤0.01% 2915
2024
Q4 		$127K Buy
23,857
+7,117
+43% +$39K ﹤0.01% 2546
2024
Q3 		$61K Buy
+16,740
New +$52.7K ﹤0.01% 3206
2024
Q2 		– Sell
-15,423
Closed -$54K – 3390
2024
Q1 		$54K Buy
+15,423
New +$28.5K ﹤0.01% 2751
2021
Q4 		– Sell
-20,487
Closed -$128K – 3876
2021
Q3 		$128K Buy
+20,487
New +$169K ﹤0.01% 3544
2021
Q2 		– Sell
-11,802
Closed -$110K – 3300
2021
Q1 		$110K Buy
+11,802
New +$93.5K ﹤0.01% 3035
2020
Q3 		– Sell
-22,300
Closed -$102K – 3559
2020
Q2 		$102K Buy
+22,300
New +$99.8K ﹤0.01% 3362
2016
Q4 		– Sell
-28,382
Closed -$85K – 3521
2016
Q3 		$85K Buy
+28,382
New +$104K ﹤0.01% 3110

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SG Americas Securities's NAGE Position: Q1 2026 in Review

SG Americas Securities reduced its Niagen Bioscience (NAGE) stake by 68% in Q1 2026, selling an estimated $201K and leaving 17,424 shares worth $77K. The position accounts for ﹤0.01% of the portfolio, ranked #2981.

SG Americas Securities first reported a position in NAGE in Q3 2016 and has held it in 11 quarters since. The position peaked at $482K in Q3 2025. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • SG Americas Securities held 17,424 shares of Niagen Bioscience worth $77K as of Q1 2026.
  • SG Americas Securities sold 37,225 Niagen Bioscience shares in Q1 2026, an estimated $201K.
  • Niagen Bioscience made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2981 holding.
  • SG Americas Securities first reported a position in Niagen Bioscience in Q3 2016 and has held it in 11 quarters since.
  • SG Americas Securities's Niagen Bioscience position peaked at $482K in Q3 2025.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.